Nuvation Bio Inc. (NUVB)

USD 2.07

(-0.48%)

Total Liabilities Summary of Nuvation Bio Inc.

  • Nuvation Bio Inc.'s latest annual total liabilities in 2023 was 16.36 Million USD , down -4.12% from previous year.
  • Nuvation Bio Inc.'s latest quarterly total liabilities in 2024 Q2 was 337.6 Million USD , up 1669.13% from previous quarter.
  • Nuvation Bio Inc. reported annual total liabilities of 17.06 Million USD in 2022, down -43.41% from previous year.
  • Nuvation Bio Inc. reported annual total liabilities of 30.15 Million USD in 2021, up 349.52% from previous year.
  • Nuvation Bio Inc. reported quarterly total liabilities of 19.08 Million USD for 2024 Q1, up 16.63% from previous quarter.
  • Nuvation Bio Inc. reported quarterly total liabilities of 16.36 Million USD for 2023 FY, down -4.12% from previous quarter.

Annual Total Liabilities Chart of Nuvation Bio Inc. (2023 - 2018)

Created with Highcharts 11.1.0YearsTotal Liabilities20182018.520192019.520202020.520212021.520222022.520230 USD10000000 USD20000000 USD30000000 USD40000000 USD

Historical Annual Total Liabilities of Nuvation Bio Inc. (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 16.36 Million USD -4.12%
2022 17.06 Million USD -43.41%
2021 30.15 Million USD 349.52%
2020 6.7 Million USD 109.36%
2019 3.2 Million USD 255.21%
2018 902 Thousand USD 0.0%

Peer Total Liabilities Comparison of Nuvation Bio Inc.

Name Total Liabilities Total Liabilities Difference
ADC Therapeutics SA 503.03 Million USD 96.747%
Alto Neuroscience, Inc. 158.3 Million USD 89.664%
Annovis Bio, Inc. 17.95 Million USD 8.893%
Biohaven Pharmaceutical Holding Company Ltd. 85.23 Million USD 80.804%
Ginkgo Bioworks Holdings, Inc. 568.19 Million USD 97.12%
Nuvation Bio Inc. 16.36 Million USD 0.0%
Arcus Biosciences, Inc. 633 Million USD 97.415%
Zymeworks Inc. 116.07 Million USD 85.904%